Astaxanthin attenuates doxorubicin-induced liver injury via suppression of ferroptosis in rats

被引:3
作者
Yin, Bowen [1 ]
Ren, Jingyi [1 ]
Liu, Xuanyi [1 ]
Lu, Miaomiao [1 ]
Huang, Dan [2 ]
Zhang, Yadong [1 ]
Zuo, Jinshi [1 ]
Wen, Rui [1 ]
Pei, Huanting [1 ]
Zhu, Siqi [1 ]
Zhang, Zhenao [1 ]
Wang, Ziyi [2 ]
Ma, Yuxia [1 ]
机构
[1] Hebei Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Hebei Key Lab Environm & Human Hlth, Shijiazhuang 050017, Peoples R China
[2] Hebei Med Univ, Undergrad Coll Publ Hlth, Shijiazhuang 050017, Peoples R China
基金
中国国家自然科学基金;
关键词
Astaxanthin; Doxorubicin; Hepatotoxicity; Iron accumulation; Ferroptosis; OXIDATIVE STRESS; ANTIOXIDANT ACTIVITY; CANCER STATISTICS; HEPATOTOXICITY; DAMAGE; CARDIOTOXICITY; INHIBITION; CHELATION;
D O I
10.1016/j.jff.2024.106437
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Hepatotoxicity is an significant side effect of doxorubicin (DOX), while astaxanthin (ASX) has the anti-liver injury biological functions. In this study, we utilized in vivo and in vitro methods to investigate the protective effect of ASX against DOX-induced hepatotoxicity and elucidate its potential mechanism. Our researchers measured liver injury indicators and the expression of ferroptosis-related protein (transferrin receptor 1 (TFRC), ferroportin 1 (FPN1), ferritin light chain (FTL), ferritin heavy chain-1 (FTH1), glutathione peroxidase 4 (GPX4), and solute carrier family 7 member 11 (SLC7A11)) in rats and HepG2 cells. We found that ASX could effectively reduce ferroptosis level and relieve a range of DOX-caused manifestations of liver injury, including inflammation and oxidative damage. ASX may play the same role as ferroptosis inhibitor, Fer-1 and DFP, in this process. The findings demonstrated that the intervention with ASX ameliorated the DOX-induced liver injury by mitigating the DOX-induced ferroptosis through inhibiting iron accumulation.
引用
收藏
页数:12
相关论文
共 63 条
[1]   Creatine Alleviates Doxorubicin-Induced Liver Damage by Inhibiting Liver Fibrosis, Inflammation, Oxidative Stress, and Cellular Senescence [J].
Aljobaily, Nouf ;
Viereckl, Michael J. ;
Hydock, David S. ;
Aljobaily, Hend ;
Wu, Tsung-Yen ;
Busekrus, Raquel ;
Jones, Brandon ;
Alberson, Jammie ;
Han, Yuyan .
NUTRIENTS, 2021, 13 (01) :1-15
[2]   Astaxanthin: Sources, Extraction, Stability, Biological Activities and Its Commercial Applications-A Review [J].
Ambati, Ranga Rao ;
Phang, Siew Moi ;
Ravi, Sarada ;
Aswathanarayana, Ravishankar Gokare .
MARINE DRUGS, 2014, 12 (01) :128-152
[3]   Hepatotoxicity by Drugs: The Most Common Implicated Agents [J].
Bjornsson, Einar S. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (02)
[4]   Impact of antioxidant supplementation on chemotherapeutic toxicity: A systematic review of the evidence from randomized controlled trials [J].
Block, Keith I. ;
Koch, Amanda C. ;
Mead, Mark N. ;
Tothy, Peter K. ;
Newman, Robert A. ;
Gyllenhaal, Charlotte .
INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (06) :1227-1239
[5]   Astaxanthin Activated the Nrf2/HO-1 Pathway to Enhance Autophagy and Inhibit Ferroptosis, Ameliorating Acetaminophen-Induced Liver Injury [J].
Cai, Xiaopeng ;
Hua, Shiyuan ;
Deng, Jingwen ;
Du, Zhen ;
Zhang, Dongxiao ;
Liu, Zhenfeng ;
Khan, Nazif Ullah ;
Zhou, Min ;
Chen, Zhi .
ACS APPLIED MATERIALS & INTERFACES, 2022, 14 (38) :42887-42903
[6]  
CAMAGGI CM, 1988, CANCER CHEMOTH PHARM, V21, P221
[7]   Ferroptosis in Liver Diseases: An Overview [J].
Capelletti, Martina Maria ;
Manceau, Hana ;
Puy, Herve ;
Peoc'h, Katell .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (14) :1-23
[8]   Astaxanthin and its Effects in Inflammatory Responses and Inflammation-Associated Diseases: Recent Advances and Future Directions [J].
Chang, Ming Xian ;
Xiong, Fan .
MOLECULES, 2020, 25 (22)
[9]  
Chen Jui-Tung, 2016, J Clin Med Res, V8, P701, DOI 10.14740/jocmr2672w
[10]   The multifaceted role of ferroptosis in liver disease [J].
Chen, Junyi ;
Li, Xiaopeng ;
Ge, Chaodong ;
Min, Junxia ;
Wang, Fudi .
CELL DEATH AND DIFFERENTIATION, 2022, 29 (03) :467-480